Mucus-Penetrating Alginate-Chitosan Nanoparticles Loaded with Berberine Hydrochloride for Oral Delivery to the Inflammation Site of Ulcerative Colitis

被引:0
作者
Lingfeng Sun
Xiangjiang Nie
Wenjie Lu
Qing Zhang
Wenyou Fang
Song Gao
Shengqi Chen
Rongfeng Hu
机构
[1] Anhui University of Chinese Medicine,Anhui Province Key Laboratory of Pharmaceutical Technology and Application, Key Laboratory of Xin’an Medicine Ministry of Education, Anhui Province Key Laboratory of Chinese Medicinal Formula
[2] China Pharmaceutical University,School of Pharmacy
[3] Nanjing Medical University,Department of Pharmacy, School of Pharmacy
来源
AAPS PharmSciTech | / 23卷
关键词
oral colon-targeted drug delivery system; mucus-penetrating; chitosan; berberine hydrochloride; ulcerative colitis;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 304 条
  • [1] Adams SM(2013)Ulcerative colitis American Family Physician. 87 699-705
  • [2] Bornemann PH(2016)Therapeutic targets in inflammatory bowel disease: current and future American Journal of Gastroenterology Supplements. 3 27-37
  • [3] Bilsborough J(2017)Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies Lancet (London, England). 390 2769-2778
  • [4] Targan SR(2017)Current and emerging therapeutic targets for IBD Nature Reviews. Gastroenterology & Hepatology. 14 269-278
  • [5] Snapper SB(2012)Phyto-chemical and pharmacological applications of Berberis aristata Fitoterapia. 83 817-830
  • [6] Ng SC(2018)Berberine inhibits macrophage M1 polarization via AKT1/SOCS1/NF-κB signaling pathway to protect against DSS-induced colitis International Immunopharmacology. 57 121-131
  • [7] Shi HY(2018)Berberine regulates Treg/Th17 balance to treat ulcerative colitis through modulating the gut microbiota in the colon Frontiers in Pharmacology. 9 571-599
  • [8] Hamidi N(2016)Berberine and inflammatory bowel disease: a concise review Pharmacological Research. 113 592-214
  • [9] Underwood FE(2020)Berberine for diarrhea in children and adults: a systematic review and meta-analysis Therapeutic Advances in Gastroenterology. 13 1-19-194
  • [10] Tang W(2019)Advances in orally-delivered pH-sensitive nanocarrier systems; an optimistic approach for the treatment of inflammatory bowel disease International Journal of Pharmaceutics. 558 201-2329